Brief: Nrx Receives Nasdaq Notice Of Listing Compliance
02/12/2022 12:19
Dec 2 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX RECEIVES NASDAQ NOTICE OF LISTING COMPLIANCE
* NRX PHARMACEUTICALS INC - ANNOUNCED RECEIVED NOTICE ON DEC
1,
2022 FROM NASDAQ INFORMING IT HAS REGAINED COMPLIANCE WITH
MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:nPn3cj8XVa
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview